Literature DB >> 24996261

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence.

Mariya Rozenblit1, Mayte Suarez-Farinas2, Avner Shemer3, Saakshi Khattri4, Patricia Gilleaudeau4, Mary Sullivan-Whalen4, Xiuzhong Zheng4, Hui Xu4, Irma Cardinale4, James G Krueger2, Emma Guttman-Yassky5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24996261      PMCID： PMC4281263          DOI： 10.1016/j.jaci.2014.05.024

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Narrow-band ultraviolet B radiation: a review of the current literature.

Authors:  Grace D Bandow; John Y M Koo
Journal:  Int J Dermatol       Date:  2004-08       Impact factor: 2.736

2.  The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system?

Authors:  Patrizia Stoitzner
Journal:  Immunol Cell Biol       Date:  2010 May-Jun       Impact factor: 5.126

3.  The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription.

Authors:  Shafaqat Ali; Antje Mohs; Meike Thomas; Jan Klare; Ralf Ross; Michael Lienhard Schmitz; Michael Uwe Martin
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

4.  Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB.

Authors:  Mayte Suárez-Fariñas; Julia K Gittler; Avner Shemer; Irma Cardinale; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-12-21       Impact factor: 10.793

Review 5.  New insights into the epidemiology of childhood atopic dermatitis.

Authors:  C Flohr; J Mann
Journal:  Allergy       Date:  2013-11-21       Impact factor: 13.146

6.  Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.

Authors:  Saakshi Khattri; Avner Shemer; Mariya Rozenblit; Nikhil Dhingra; Tali Czarnowicki; Robert Finney; Patricia Gilleaudeau; Mary Sullivan-Whalen; Xiuzhong Zheng; Hui Xu; Irma Cardinale; Cristina de Guzman Strong; Juana Gonzalez; Mayte Suárez-Fariñas; Jim G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2014-04-29       Impact factor: 10.793

7.  Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.

Authors:  H Granlund; P Erkko; M Sinisalo; S Reitamo
Journal:  Br J Dermatol       Date:  1995-01       Impact factor: 9.302

8.  IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.

Authors:  Jingling Su; Tengfei Chen; Xin-Ying Ji; Changqin Liu; Praveen K Yadav; Ruijin Wu; Pingchang Yang; Zhanju Liu
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

Review 9.  New insights into atopic dermatitis: role of skin barrier and immune dysregulation.

Authors:  Donald Y M Leung
Journal:  Allergol Int       Date:  2013-06       Impact factor: 5.836
  9 in total
  5 in total

1.  Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczema.

Authors:  Martina S Elias; Heather A Long; Carla F Newman; Paul A Wilson; Andrew West; Paul J McGill; Keith C Wu; Michael J Donaldson; Nick J Reynolds
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

Review 2.  Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.

Authors:  Matthew Moyle; Ferda Cevikbas; Jamie L Harden; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2019-04-15       Impact factor: 3.960

Review 3.  Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches.

Authors:  Donald Y M Leung; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2014-10       Impact factor: 10.793

Review 4.  Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics.

Authors:  Yasaman Mansouri; Emma Guttman-Yassky
Journal:  J Clin Med       Date:  2015-04-29       Impact factor: 4.241

5.  Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways.

Authors:  David A Ewald; Dana Malajian; James G Krueger; Christopher T Workman; Tianjiao Wang; Suyan Tian; Thomas Litman; Emma Guttman-Yassky; Mayte Suárez-Fariñas
Journal:  BMC Med Genomics       Date:  2015-10-12       Impact factor: 3.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.